Across TCGA pan-cancer cohorts, RNA5SP248 RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of RNA5SP248’s most consistent transcriptional readouts.
The strongest signal is observed in lung adenocarcinoma (LUAD), where RNA5SP248 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RNA5SP248 is over-expressed in tumor.
LUAD and KIRC are the cancer types where RNA5SP248 tumor–normal differential expression is most reproducible.